Silvercrest Asset Management Group LLC Astrazeneca PLC Transaction History
Silvercrest Asset Management Group LLC
- $14.7 Billion
- Q3 2025
A detailed history of Silvercrest Asset Management Group LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 244,887 shares of AZN stock, worth $21.9 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
244,887
Previous 249,295
1.77%
Holding current value
$21.9 Million
Previous $17.4 Million
7.85%
% of portfolio
0.13%
Previous 0.12%
Shares
14 transactions
Others Institutions Holding AZN
# of Institutions
1,510Shares Held
501MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...